Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer.
In Hee LeeSoo Jung LeeByung Woog KangYee Soo ChaeDongwon BaekSoyoon HwangHye Jin KimSu Yeon ParkJun Seok ParkGyu Seog ChoiJae Chul KimJong Gwang KimPublished in: Cancer chemotherapy and pharmacology (2016)
CRT with two cycles of a FMC regimen was found to be feasible for patients with anal squamous carcinoma. Further study is warranted to evaluate the efficacy of CRT with a FMC regimen.